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Abstract
Background: Atrial fibrillation (AF) occurs in about 27% to 40% of post cardiac surgery patients. AF following
coronary artery bypass graft surgery (CABG) is associated with a two-fold increase in morbidity and mortality.
Various demographic risk factors and medications have been studied to predict the occurrence of this arrhythmia.
The role of angiotensin related medications on the occurrence of AF in CABG patients is not determined.
Methods: Retrospective clinical and statistical analysis was made of all the patients who had undergone CABG
surgery at Lehigh Valley Hospital during the years 2005 and 2006. Patients with chronic AF and those undergoing
valvular surgery with CABG were excluded. Statistic analysis included chi-square test for categorical and student t-
test for continuous variables.
Results: 757 patients (560 males and 197 females) were studied. AF occurred in 19% of the patients. Age (70.5 vs.
65.1, p < 0.005. OR per year of age: 1.02, 95%CI: 1.018-1.023) and presence of hypertension (OR: 1.92, 95%CI: 1.086-
3.140, p = 0.025) were significantly associated with occurrence of AF. Neither ARBs (OR: 0.78, 95%CI: 0.431-1.410, p
= 0.41) nor ACE inhibitors (OR: 1.01, 95%CI: 0.753-1.608, p = 0.63) reduced the occurrence of post operative AF.
Patients with post operative AF had a significantly longer hospital stay (9.5 +/- 5.4 days vs. 6.9 +/- 4.3 days, p =
0.001).
Conclusions: Advanced age and presence of hypertension were independent predictors of post-CABG AF. Patients
with post operative AF had significantly longer hospital stay. Neither ARBs nor ACE inhibitors were associated with
reduction of post-surgical AF. Further studies are needed to better delineate the role of angiotensin related
medications on reduction of post-surgical AF.
Background
Atrial fibrillation (AF) occurs in about 27% to 40% of
post cardiac surgery patients [1]. The presence of this
arrhythmia following coronary artery bypass graft sur-
gery (CABG) is associated with a two-fold increase in
cardiovascular morbidity and mortality [2]. Post opera-
tive AF is associated with a higher occurrence of heart
failure and cerebral ischemic accidents, both resulting in
longer hospital stay, and consequently in higher hospital
costs [3-6]. The etiology of postoperative AF is not well
defined, although recent studies suggest a multi-factorial
mechanism, which includes oxidative stress, inflamma-
tion, atrial fibrosis, excessive production of catechola-
mines, changes in autonomic tone and in the expression
of connexins [7-11]. Multiple investigations have been
performed to identify the demographic risk factors, asso-
ciation of medications and the predictors of post opera-
tive AF, but there is no conclusive information [12].
Epidemiological studies in non-surgical patients have
* Correspondence: nasirshariff@gmail.com
1Department of Medicine, Lehigh Valley Hospital, Allentown, Pennsylvania,
USA
Shariff et al. BMC Cardiovascular Disorders 2010, 10:7
http://www.biomedcentral.com/1471-2261/10/7
© 2010 Shariff et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.shown that the use of angiotensin-converting enzyme
inhibitors (ACEI) and angiotensin receptor blockers
(ARBs) have an overall effect of 18% risk reduction in
new-onset AF across the trials, and 43% risk reduction
in patients with heart failure [13]. The present study
was aimed at identifying the preoperative demographic
predictors and the effects of ACEI and ARBs on the
occurrence of AF in patients who underwent CABG
surgery.
Methods
A retrospective evaluation of patients who have under-
gone CABG surgery at Lehigh Valley Hospital was done.
Patients were identified by ICD-9 surgical code for cor-
onary artery bypass grafting. Data including baseline
characteristics, past medical history, medicine use, and
hospital course were extracted from an electronic medi-
cal record database. Each chart was reviewed and data
entered by the investigators NS and MQM. Postopera-
tive AF was defined as an entry into the case report
form or by detection on the postoperative electrocardio-
gram. No distinction was made whether the arrhythmia
was associated with symptoms or not. Details of medica-
tions received in the pre-operative period were noted.
Included cases were divided into three groups: those on
ACEI, those on ARBs and those on neither of these
medications. Consecutive patients undergoing coronary
arterial bypass surgery between January 2005 and
December 2006 were included in the study. Patients
younger than 18 years, those who were undergoing valv-
ular surgery in addition to the CABG and patients with
known AF at the time of going for the surgery were
excluded from the study. Prior medical illness including
hypertension and diabetes mellitus were studied as pos-
sible contributing causes of post surgical AF. Statistical
analysis was conducted using SPSS 15.0 software. Group
comparisons were performed using chi-square, t-test,
ANOVA and non-parametric Kruskal-Wallace tests
where appropriate. For those measures showing signifi-
cant differences, appropriate odds ratios and 95% confi-
dence intervals were calculated to provide ease of
interpretation. The institutional review board at Lehigh
Valley Hospital granted ethical approval for this study.
Results
757 patients fulfilled the criteria and were included in
the study. All the patients had on-pump CABG surgery.
There were 560 males and 197 females. The mean age
of the patients was 66.1 years with SD of 10.9 years.
The average left ventricular ejection fraction (LVEF) was
51.2%. The duration of hospital stay ranged from 1 day
to 45 days (mean 7.5 days with SD of 4.5 days). 634
(83%) patients were known to have hypertension, 606
(80%) were on beta-blockers, 260 (27%) on ACEI, and
94 (12%) were on ARBs. There were 262 (35%) patients
with diabetes mellitus. 476 (63%) patients had history of
smoking. 149 (20%) had COPD at the time of the sur-
gery. Post operative AF occurred in 144 (19%) of the
patients.
Comparison of patients with and without AF following
the CABG
Patients with AF following the CABG were noted to be
older than those without the event, which was statisti-
cally significant (70.5 +/- 8.1 years vs. 65.1 +/- 11.2
years, p < 0.001). The odd ratio per year of age of devel-
oping AF after CABG was 1.02 with 95%CI of 1.018-
1.023. Patients with AF had a significantly longer hospi-
tal stay (9.5 +/- 5.4 days vs. 6.9 +/- 4.3 days, p = 0.001).
The occurrence of AF was not different in males as
compared to females. There was no association of the
arrhythmia with either smoking or history of COPD
(Table 1). There was a significantly higher incidence of
AF in hypertensive patients (OR: 1.92, 95%CI: 1.086-
3.140, p = 0.025), but it was noted that on matching for
age, this effect was lost. On subgroup analysis of hyper-
tensive patients there was no association of occurrence
of AF with the variables studied except as mentioned
for age. Patients with diabetes mellitus had a higher
incidence, while patients on ARBs had a lower incidence
of AF, though neither were statistically significant. ACEI
and beta-blockers had no effect on post-surgical AF, so
was the case with Aspirin and Clopidogrel (Table 1).
Subgroup analysis of diabetic patients
On subgroup analysis of diabetic patients (Table 2),
there was no association of AF with gender, smoking, or
COPD. Again there was a noted higher incidence in
hypertensive patients (p = 0.04). There was noted reduc-
tion in the occurrence of AF in patients who were on
beta-blockers (p = 0.78) and ARBs (p = 0.45). It was
also noted that there were fewer events patients on
aspirin (p = 0.13). Patients with AF were noted to be
older (71.2 +/- 8.6 years vs. 66.3 +/- 10.8 years, p =
0.002) and had a longer hospital stay (10.1 +/- 4.3 days
vs. 7.7 +/- 5.3 days, p = 0.002).
Subgroup analysis of patients who are older than 65
years with hypertension and diabetes
On additional subgroup analysis of these patients; no
characteristic was identified with an increased occur-
rence of AF although there was a numerically lower
propensity for AF in those patients receiving ARBs, clo-
pidogrel, aspirin, beta-blockers and smokers although
none of these was statistically significant (Table 3).
Comparison of patients on ACEI or ARBs with those who
were not on these medications
260 patients were on ACEI, 94 were on ARBs and 403
patients were on neither of these medications. AF
occurred in 20% of patients on neither ACEI nor ARBs.
20% of patients on ACEI and 16% of patients on ARBs
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less occurrence of AF in patients on ARBs, this was not
statistical significant (OR: 0.78, 95%CI: 0.431-1.410, p =
0.41). We did note that patients on ARBs were signifi-
cantly older than patients who were not on ARBs (68.2
+/- 9.2 yrs vs. 65.8 +/- 11.1 yrs. p = 0.05). Further eva-
luation with matching for age showed no significant
effect of ARBs on occurrence of AF. Patients who were
noted to benefit the most were those between 80 and 89
years of age (21% vs 30%, p = 0.15). Of the 28 patients
in this age group who were on ARBs, 6 had post opera-
tive AF as against 59 of 199 patients who were not on
this medication.
Discussion
AF is a common cardiac arrhythmia following cardi-
othoracic surgery. AF occurs in about 27% to 40% of
post cardiac surgery patients [1]. AF most frequently
occurs in the first 2 to 3 days after cardiothoracic sur-
gery [14]. The presence of this arrhythmia following
coronary artery bypass graft surgery is associated with a
two-fold increase in cardiovascular morbidity and mor-
tality [2]. There have been various studies suggesting the
positive effects of ACEI and ARBs on the occurrence of
this complication, though it is still controversial [15,16].
In our retrospective study, we looked at patients who
underwent CABG without valvular surgery, on the con-
tributing factors and effects of various cardiac medica-
tions on the occurrence of post surgical AF. In our
analysis AF occurred in 19% of patients. The reduced
incidence of AF amongst our patients as compared to
other quoted studies [1,15,16] is possibly attributed to
the exclusion of patients who were also undergoing
valvular surgery, which is known to increase the inci-
dence of the AF. Increasing age was noted to be asso-
ciated with higher occurrence of AF, whereas gender,
diabetes, and left ventricular ejection fraction were not
associated with AF. Patients with AF had a significantly
longer hospital stay (9.5 +/- 5.4 days vs. 6.9 +/- 4.3 days,
p = 0.001). The noted influence of age as the positive
predictor of occurrence of AF has been noted previously
[17]. We did see a higher occurrence of AF among
Table 1 Comparison of discrete variables between patients who developed AF following CABG with those who did not
have the arrhythmia following the surgery (Chi-squares test)
Particulars (patients in the group) AF positive (n = 144) AF negative (n = 613) Odds Ratio P value
Males (558) 107 456 0.97 0.89
Smoker (476) 86 390 0.87 0.45
COPD (149) 25 124 0.84 0.46
Hypertension (634) 129 505 1.92 0.017
Diabetes (262) 56 206 1.27 0.21
Aspirin (693) 133 560 1.16 0.66
Clopidogrel (261) 56 205 1.27 0.21
Beta-blockers (606) 118 488 1.17 0.51
ACEI(260) 52 208 1.01 0.75
ARB (94) 15 79 0.78 0.41
Statins (557) 107 450 1.28 0.71
Sternal infections (1) 1 0 - 0.38
Prolonged ventilation (27) 10 17 2.64 0.01
Table 2 Comparison amongst diabetic patients of various factors that could contribute to post operative AF (n = 262).
Particulars (patients in the group) AF positive (n = 56) AF negative (n = 206) Odds Ratio P value
Males (184) 38 146 1.15 0.66
Smokers (147) 29 118 0.80 0.46
COPD (43) 5 38 0.43 0.09
Hypertension (240) 55 185 6.24 0.04
Aspirin (240) 49 191 0.47 0.13
Clopidogrel (90) 19 71 0.96 0.90
ARB (41) 7 34 0.71 0.45
ACEI (112) 26 86 1.19 0.57
Beta-blockers (212) 45 167 0.90 0.78
Statins (198) 44 154 1.57 0.56
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matching to age, this effect was lost. This finding reaf-
firming the role of age was unique to our study.
Use of ACEI and ARBs as a medication to reduce AF
following CABG has not been fully studied to date.
ACEI and ARBs are routinely used perioperatively and if
they were to provide protection against AF, this would
provide additional rationale to using these agents in all
patients undergoing CABG. The Renin-Angiotensin sys-
tem has been shown to play a key role in vascular
inflammation, cardiac remodelling, fibrosis and apopto-
sis, and autonomic control. Agents that block the renin-
angiotensin system have been reported not only to pre-
vent left atrial dilation and atrial fibrosis but also to
slow conduction velocity in the heart, explaining the
r e d u c t i o no fA Fi np o s tC A B Gp a t i e n t s[ 1 8 - 2 0 ] .A tt h e
same time there are reports of increase in AF with these
agents [15]. An explanation for the increased occurrence
of AF in post-operative patients on ACEI and ARBs is
thought to be attributed to the higher prevalence of
hypertension and left ventricular hypertrophy in these
patients [15].
In our study we compared the effects of ACEI and
ARBs as separate groups on the occurrence of AF; this
has not been done previously. Interestingly we noted
that though not statistically significant, patients on
ARBs had fewer occurrences of AF post operatively
unlike patients who were on ACEI. Similar differences
have been noted between the two medications in rela-
tion to reduction of cerebro-vascular accidents [21]. The
likely explanation for this finding is not known, though
there are a few hypothetical explanations for its occur-
rence. ACEI antagonize the effects of AT-1 and AT-2
receptors while ARBs block the AT-1 and stimulate AT-
2 receptors. Stimulation of AT-2 receptors counteracts
some effects of AT-1 receptors and may have antiproli-
ferative and cardioprotective action. In addition the
ACEI do not affect angiotensin II production via non-
ACE pathways, whereas ARBs antagonize all effects con-
sequent upon AT-1 receptor activation. Chymase activ-
ity (non-ACE pathway) is present in the human heart
tissue extract and is higher in the left atrium than in
other chambers [22]. In a recent study, treatment with
Valsartan was not associated with a reduction in the
incidence of recurrent AF [23]. This study enrolled
patients who were in sinus rhythm but had previous
documented episodes of AF and they looked at the inci-
dence of reoccurrence of the arrhythmia. Half of the
studied patients were on other antiarrhythmic medica-
tions like amiodarone, sotalol and class I antiarrhythmic
agents, which was quite in contrast to our study popula-
tion. Though there was only a marginal reduction of
occurrence of AF in the treated population in that
study, we could speculate that there could have been a
bigger benefit in medication naive patients. It is also
well established that the etiology of AF following CABG
is very different from non-surgical patients who were
studied in the GISSI-AF trial. In our study we note that
patients on ARBs were significantly older than patients
who were not on ARBs. Since we had seen that age was
significantly associated with occurrence of AF; further
evaluation with matching the age was done. On match-
ing for age - there was no significant reduction of inci-
dence of occurrence of AF in any particular age group
though patients between the age of 80 and 89 years
noted to be most benefited with ARBs.
Our study had some limitations; firstly, we were not
able to assess left atrial size and left ventricular hyper-
trophy which are known risk factors of post operative
AF, and would recommend that this data be included in
further studies. Secondly, as this was a cohort study,
investigators did not dictate the use of ACEI or ARB or
its dosages, nor had any control on the duration of
medications. This lack of randomisation in observational
studies could introduce both confounding factors and
biases. We addressed most of the confirmed risk factors
by matching patients in our statistical analysis.
Conclusion
Advanced age and presence of hypertension were inde-
pendent predictors of post-CABG AF. Patients with post
operative AF had significantly longer hospital stay.
Table 3 Comparison of various factors amongst patients older than 65 years, positive history of hypertension, and
diabetes for occurrence of post-operative AF (n = 157).
Particulars AF positive (n = 56) AF negative (n = 206) Odds Ratio P value
Males (108) 29 79 0.98 0.97
Smokers (85) 20 65 0.70 0.32
Aspirin (143) 37 106 0.63 0.42
Clopidogrel (57) 13 44 0.72 0.40
ARB (32) 5 27 0.44 0.11
ACEI (71) 19 52 1.01 0.99
Beta-blockers (131) 34 97 0.79 0.61
Statins (120) 33 87 1.70 0.50
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reduction of post-surgical AF. Further studies are
needed to better delineate the role of angiotensin related
medications on reduction of post-surgical AF.
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